Commercial Analytics Platform
Gain precision insights for improved commercial effectiveness
Platform · Cloud SaaSCompany source
Company profile
About IQVIA
IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, leveraging AI to optimize clinical trials.
Company description IQVIA official website
Primary marketClinical Trials & Research
Commercial modelCommercial information available on request
Work at IQVIA?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Allergy & Respiratory
- Biosimilars
- Cardiovascular
- Cell & Gene Therapy
- Central Nervous System
- Dermatology
- Endocrinology
- GI & Hepatology
- Infectious Diseases & Vaccines
- Nephrology
- Obesity
- Oncology & Hematology
- Ophthalmology
- Pediatrics
- Rare Diseases
- Reproductive Health
- Rheumatology
Who it serves
- Consumer Health
- Emerging Biopharma
- Financial Institutions
- Generics
- Government
- MedTech
- Patient Associations
- Payers
- Pharmaceutical Manufacturers
- Providers
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsArgentina · Australia & NZ · Belgium · Brazil · Bulgaria · Canada · Central America and Caribbean · China · Colombia · Czech Republic · Ecuador · France · Germany · Greece · Hungary · India · Ireland · Israel · Italy · Japan · Kazakhstan · Korea · Mexico · Middle East and Africa · Netherlands · Nordics · Poland · Romania · Russia · Slovakia · Southeast Asia · Spain · Sri Lanka · Switzerland · Turkey · Ukraine · United Kingdom · United States
Company sourceOfficial website
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Electronic Clinical Outcome Assessments (eCOA)
Capture high-quality patient data digitally
Software · Cloud SaaSCompany source
Health Data Apps & AI
Streamline research with the largest agnostic health data catalog
Platform · Cloud SaaSCompany source
Health Research Space
Enable secure, collaborative access to real-world data
Platform · Cloud SaaSCompany source
IQVIA AI
Healthcare-grade AI for life sciences and healthcare
Platform · Cloud SaaSCompany source
Natural Language Processing Platform
Extract insights at scale from unstructured text
Platform · Cloud SaaSCompany source
Patient Engagement Suite
Connect with patients through integrated technology
Platform · Cloud SaaSCompany source
Patient Registries
Generate real-world insights by capturing patient outcomes
Platform · Cloud SaaSCompany source
Pharmacovigilance Platform
Safety monitoring powered by expertise and advanced technology
Platform · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Costs and outcomes of group B Streptococcus (GBS) screening strategies in France for prevention of neonatal early-onset GBS disease.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · Dec 1, 2026
Response to letter to the editor: sustained on/off-treatment disease control with abrocitinib for moderate-to-severe atopic dermatitis.The Journal of dermatological treatment · Dec 1, 2026
Safety and effectiveness of omalizumab for chronic spontaneous urticaria inadequately controlled with H1 antihistamines in Chinese adolescents: a real-world, prospective, multicenter study.The Journal of dermatological treatment · Dec 1, 2026
Sustained on/off-treatment disease control with abrocitinib for moderate-to-severe atopic dermatitis.The Journal of dermatological treatment · Dec 1, 2026
Emergency Physician Perceptions and Experiences in Acute Pain Management: A Qualitative Interview Study.Journal of the American College of Emergency Physicians open · Oct 1, 2026
Antidepressant Use During Pregnancy and Birth Outcomes: Analysis From the UK, Norway, and Sweden.Pharmacoepidemiology and drug safety · Sep 1, 2026
Clinical validation
Clinical-trial records
Tezspire Cardiac Events PASSNCT06951867 · Sponsor · RECRUITING
Anifrolumab Pregnancy StudyNCT07049653 · Sponsor · RECRUITING
Pacritinib Effectiveness in Real-world SettingsNCT07774455 · Sponsor · NOT YET RECRUITING
Anifrolumab Malignancy and Serious Infections StudyNCT07000110 · Sponsor · RECRUITING
I-OPERA: A European Study Testing a New Way to Do Health Research.NCT07759544 · Sponsor · NOT YET RECRUITING
A Pilot Study of BXCL701 in Patients With Pancreatic CancerNCT04123574 · Sponsor · WITHDRAWN
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Faster decision making
Clinical development optimization through AI and analytics
Reduced risk
Clinical trial execution and R&D strategy
Improved enrollment strategies
Patient engagement and site-centric solutions
Accelerated time to market
Launch excellence and regulatory compliance
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Seba Saad
Centralized Monitor
Eric Odongo
Senior Statistical Programmer
Mohamed Mostafa
Vice President & General Manager Strategic Partnerships and Growth Markets Middle East & Africa
Yuichi Yuda
Vice President of Corporate Strategy, PR,Business Development and Business Operations at IQVIA Japan
Abdessamad Charkaoui
Chief Financial Officer of Morocco
Gabriela Lerma Valencia
Commercial Engagement Services (CES) Latam Regional Leader
Bella Huang
Assistant General Counsel
Emilio Nicoli
Principal Enterprise Architect
06 · Company updates
Updates from IQVIA
Recent articles published on IQVIA's official website.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Clinical Trials & Research
Companies using AI to optimize clinical trial design, accelerate patient recruitment, match patients to trials, predict trial outcomes, or improve clinical research efficiency. Includes patient enrollment and screening platforms, AI-powered trial matching, and tools that reduce the time and cost of bringing new treatments to market.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.